Clinical Trial Update: A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of the MD-15 intraocular lens in aphakic eyes after cataract surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• MD-15 Intraocular Lens

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Cataract | Phase 3 | Status: COMPLETED